European Medicines Agency update on the safety of Tamiflu
Two cases of alleged \'suicide\' associated with treatment of influenza (involving a 17-year-old boy in February 2004 and a 14-year-old boy in February 2005) were reported to the EMEA. In both cases the adolescents exhibited abnormal/disturbed behaviour, which led to their deaths. So far, no causal relationship has been identified between the use of Tamiflu and psychiatric symptoms (such as hallucination and abnormal behaviour). The EMEA stresses that the assessment of psychiatric events during Tamiflu treatment is difficult because:
- - Other medicines are often taken at the same time as Tamiflu
- - Patients with influenza and a high fever can show psychiatric symptoms. This is particularly relevant for children and elderly patients.
All adverse reactions are monitored and assessed by the Agency\'s scientific committee, the Committee for Medicinal Products for Human Use (CHMP) on a continuous basis.
The CHMP, at its meeting of 14-17 November 2005, decided to request the Marketing Authorisation Holder (Roche) of Tamiflu to provide a cumulative safety review of all available data on serious psychiatric disorders, including all case reports with a fatal outcome where Tamiflu was involved. The EMEA will make a statement on the outcome of this evaluation.
1. - More information on Tamiflu is available in the European Public Assessment Report on the EMEA website, which can be found here emea.eu.int/humandocs/Humans/EPAR/tamiflu/tamiflu.htm.
2. - The EMEA has produced a summary report on the use of antivirals in case of pandemic influenza, which is available on the EMEA website here: emea.eu.int/pdfs/human/pandemicinfluenza/33997205.pdf.
3. - This press release, together with other information on the work of the EMEA is available on the EMEA website: http://www.emea.eu.int.
There are no references listed for this article.
Please use one of the following formats to cite this article in your essay, paper or report:
Santos, Harry. "European Medicines Agency update on the safety of Tamiflu." Medical News Today. MediLexicon, Intl., 20 Nov. 2005. Web.
25 Jun. 2017. <http://www.medicalnewstoday.com/releases/33860.php>
Santos, H. (2005, November 20). "European Medicines Agency update on the safety of Tamiflu." Medical News Today. Retrieved from
Please note: If no author information is provided, the source is cited instead.
Contact our news editors
For any corrections of factual information, or to contact our editorial team, please see our contact page.
Copyright Medical News Today: Excluding email/sharing services explicitly offered on this website, material published on Medical News Today may not be reproduced, or distributed without the prior written permission of Medilexicon International Ltd. Please contact us for further details.